logo-loader
viewMota Ventures

Mota Ventures to launch an immune support CBD line

The decision is inspired by how the company’s pure herbal immunity blend, promoted under the First Class brand, is firing up sales

Mota Ventures - Mota Ventures is launching an immune support CBD line
Mota Ventures is launching new immune boosting products which contain CBD and vitamins B3, B12 and C with zinc

Mota Ventures Corp (CSE:MOTA) (OTCMKTS:PEMTF) said Monday that it is launching an immune support CBD line inspired by the traction it is getting from the March 14 launch of its Pure Herbal Immunity Blend, which is marketed under its First Class brand. 

In a statement, the Vancouver-based company said its all-natural Immunity Blend snapped up 1,838 new customers within a week. The formulation includes 100% pure essential oils, including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus, rosemary, peppermint, spearmint and oregano, the company said.

Given the pent-up demand for pure and natural products to support the immune system, Mota Ventures said it will launch an immune support CBD oil, along with an elderberry gummy product. The new immune CBD product contains CBD, and vitamins B3, B12, and C with zinc.

READ: Mota Ventures' prized First Class CBD brand clocks record sales of about C$3 million in February

“As our customers around the globe face challenges in their daily lives, we are working diligently to provide products to help families with natural health needs,” said Mota Ventures CEO Ryan Hoggan.

“Our supply chain is operating uninterrupted and we are quickly working to expand our immune support product line. We stand ready to continue to adapt to market changes and innovate new products to take advantage of the numerous opportunities ahead,” he added.

The company said it also plans to sell immune-boosting products in Europe through its Sativida brand, which currently retails in European countries including Spain, Portugal, Austria, Germany, France and the United Kingdom.

Mota Ventures added that it anticipates completing a transaction with VIDA BCN LABS SL (Spain) and Sativida OU (Estonia) to acquire producer and online CBD retailer Sativida in “the next seven days.” As a part of the deal, Mota Ventures will acquire the both Sativida’s intellectual property and trade name, but it will license both back to Sativida in exchange for a royalty associated with the gross revenue generated.

On January 10, Mota Ventures said the transaction will consist of an initial €2 million (US$2.2 million) and an earn-out component of three milestone payments based on Sativida’s revenue.

Mota Ventures, based in Vancouver, aims to become a vertically integrated CBD company with operations in Europe and the Americas. It operates a 2.5 hectare growing site in Colombia and has begun to establish sales and distribution channels through the acquisition of the Sativida and First Class CBD brands.

Contact the author Uttara Choudhury at [email protected]

Follow her on Twitter: @UttaraProactive 

Quick facts: Mota Ventures

Price: 0.395 CAD

CSE:MOTA
Market: CSE
Market Cap: $39.38 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Mota Ventures named herein, including the promotion by the Company of Mota Ventures in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Mota Ventures sees strong sales increase amid COVID-19 Crisis

Mota Ventures (CSE: MOTA-OTCMKTS: PEMTF) CEO Ryan Hoggan joined Steve Darling from Proactive Vancouver to discuss how the company is doing during the Corona Virus crisis and how it has affected sales. Hoggan also told Proactive about a new product line the company has started and how excited...

on 1/4/20

3 min read